TY - JOUR
T1 - Bias reported by family caregivers in support received when assisting patients with cancer-related decision-making
AU - Dionne-Odom, J. Nicholas
AU - Ornstein, Katherine A.
AU - Azuero, Andres
AU - Harrell, Erin R.
AU - Gazaway, Shena
AU - Watts, Kristen Allen
AU - Ejem, Deborah
AU - Bechthold, Avery C.
AU - Lee, Kyungmi
AU - Puga, Frank
AU - Miller-Sonet, Ellen
AU - Williams, Grant R.
AU - Kent, Erin E.
N1 - Funding Information:
The original CancerCare survey received funding support from Amgen, Merck, Regeneron, Eisai, Pfizer, Jazz, Astellas, and Glaxo‐Smith Kline. There was no research support for this analysis.
Publisher Copyright:
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
PY - 2023/2
Y1 - 2023/2
N2 - Background: Family caregivers play an increasing role in cancer treatment decision-making. We examined bias reported by family caregivers in the support they and their patient received from their healthcare team when making these decisions, including associations with distress. Methods: Analysis of 2021 national survey data of family caregivers of patients with cancer (N = 2703). Bias experienced in decision support was assessed with the item: “Have you felt that the support you and the person with cancer have received for making cancer-related decisions by your doctor or healthcare team has been negatively affected by any of the following?” Check-all-that-apply response options included: age, race, language, education, political affiliation, body weight, insurance type or lack of insurance, income, religion, sexual orientation, and gender/sex. Chi-square and regression analyses assessed associations between bias and caregiver distress (GAD-2, PHQ-2). Results: Of 2703 caregiver respondents, 47.4% (n = 1281) reported experiencing ≥1 bias(es) when receiving decision support for making cancer-related decisions. Bias was more prevalent among younger caregivers, males, transwomen/men or gender non-conforming caregivers, racial/ethnic minorities, and those providing care over a longer time period. The odds of having high anxiety (GAD-2 scores ≥ 3) were 2.1 times higher for caregivers experiencing one type of bias (adjusted OR, 2.1; 95% CI, 1.6–2.8) and 4.2 times higher for caregivers experiencing ≥2 biases (adjusted OR, 4.2; 95% CI, 3.4–5.3) compared to none. Similar results were found for high depression scores (PHQ-2 scores ≥ 3). Conclusions: Nearly half of caregivers involved in their care recipients' cancer-related decisions report bias in decision support received from the healthcare team. Experiencing bias was strongly associated with high psychological distress.
AB - Background: Family caregivers play an increasing role in cancer treatment decision-making. We examined bias reported by family caregivers in the support they and their patient received from their healthcare team when making these decisions, including associations with distress. Methods: Analysis of 2021 national survey data of family caregivers of patients with cancer (N = 2703). Bias experienced in decision support was assessed with the item: “Have you felt that the support you and the person with cancer have received for making cancer-related decisions by your doctor or healthcare team has been negatively affected by any of the following?” Check-all-that-apply response options included: age, race, language, education, political affiliation, body weight, insurance type or lack of insurance, income, religion, sexual orientation, and gender/sex. Chi-square and regression analyses assessed associations between bias and caregiver distress (GAD-2, PHQ-2). Results: Of 2703 caregiver respondents, 47.4% (n = 1281) reported experiencing ≥1 bias(es) when receiving decision support for making cancer-related decisions. Bias was more prevalent among younger caregivers, males, transwomen/men or gender non-conforming caregivers, racial/ethnic minorities, and those providing care over a longer time period. The odds of having high anxiety (GAD-2 scores ≥ 3) were 2.1 times higher for caregivers experiencing one type of bias (adjusted OR, 2.1; 95% CI, 1.6–2.8) and 4.2 times higher for caregivers experiencing ≥2 biases (adjusted OR, 4.2; 95% CI, 3.4–5.3) compared to none. Similar results were found for high depression scores (PHQ-2 scores ≥ 3). Conclusions: Nearly half of caregivers involved in their care recipients' cancer-related decisions report bias in decision support received from the healthcare team. Experiencing bias was strongly associated with high psychological distress.
KW - bias
KW - cancer
KW - decision-making
KW - discrimination
KW - family caregiver
UR - http://www.scopus.com/inward/record.url?scp=85136686241&partnerID=8YFLogxK
U2 - 10.1002/cam4.5182
DO - 10.1002/cam4.5182
M3 - Article
AN - SCOPUS:85136686241
SN - 2045-7634
VL - 12
SP - 3567
EP - 3576
JO - Cancer Medicine
JF - Cancer Medicine
IS - 3
ER -